Burning Mouth Disorder (BMD) - A Neuropathic Pain Disorder

Sponsor
Markus R. Fussnegger (Other)
Overall Status
Unknown status
CT.gov ID
NCT00504387
Collaborator
Deutsche Gesellschaft für Zahn-, Mund- und Kieferheilkunde e.V. (Other)
12
1
80
0.1

Study Details

Study Description

Brief Summary

Oral burning can have a multitude of reasons. Recent neurophysiologic study results suggest that a primary burning mouth disorder (BMD) may be a peripheral and/or a central neuropathic disorder. The aim of this study is to first identify patients with a primary burning mouth disorder by excluding other possible causes for oral burning. By means of qualitative and quantitative sensory testing and a gustatory examination in the individual patient the investigators want to find out whether neurosensory differences exist between patients with a primary BMD and controls and whether gustatory and neurosensory deficits always coexist in BMD-patients.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Oral burning can have many different etiologies. Secondary burning mouth disorders (BMD) due to systemic (i.e. diabetes, nutritional deficiencies, allergies), local (i.e. Candidiasis, Lichen planus) or functional factors (i.e. tongue parafunctional activities, mouth breathing) are usually fairly easy to identify and are treated by eliminating the respective cause. A primary BMD as a specific disease is a challenging disorder with regard to assessment and treatment for both, the patient and the dentist. The prevailing hypothesis of a predominantly psychological cause is questioned by recent research results. The typical burning sensation, the partly efficacy of medication that is usually used in chronic, neuropathic pains and recent neurophysiologic studies and finally the finding of a degeneration of epithelial nerve fibers in BMD patients give reason to assume a peripheral and/or central neuropathic etiology. That is, the transduction of nociceptive stimuli in the orofacial region and the transmission and modulation of the nociceptive input might be altered. The hypothesis of a disorder of the gustatory system assumes that gustatory input has an inhibitory influence on the trigeminal nociceptive system. A hypogeusia or ageusia, maybe caused by peripheral nerve degeneration that has been found in BMD patients would therefore lead to a decreased gustatory input which in turn gives way to a central disinhibition of trigeminal nociception, leading to a more painful perception in the oral region. The aim of this study is to first identify patients with a primary burning mouth disorder by excluding other possible causes for oral burning. By means of qualitative and thermal quantitative sensory testing and a gustatory examination in the individual patient we want to find out whether neurosensory differences exist between patients with a primary BMD and controls and whether gustatory and neurosensory deficits always coexist in BMD-patients.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    12 participants
    Time Perspective:
    Prospective
    Official Title:
    Burning Mouth Disorder (BMD) - a Neuropathic Pain Disorder? An Investigation Using Qualitative and Quantitative Sensory Testing (QST)
    Study Start Date :
    Apr 1, 2007
    Anticipated Primary Completion Date :
    Dec 1, 2013
    Anticipated Study Completion Date :
    Dec 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    A: Patients

    Patients with a primary burning mouth disorder Pain (VAS 0-10): 3<x<9 Patient understands and speaks german Age: >18 years

    B: Controls

    Age and sex matched persons/patients who do not have any history of an oral burning sensation or a burning mouth disorder.

    Outcome Measures

    Primary Outcome Measures

    1. Neurosensory differences between Burning Mouth Disorder patients and controls. []

      The aim of the present study is to identify patients with idiopathic BMD. By way of qualitative and quantitative sensory testing (QST) and gustatory tests we want to find out whether neurosensory differences exist between patients with BMD and controls without any oral burning sensation.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Primary burning sensation of the tongue, lip or other oral structure

    • Average pain intensity between 3 and 9 (VAS-Scale 0-10)

    • Written, informed consent

    • patient speaks German

    • Age > 18 years old

    Exclusion Criteria:
    • Tumor

    • HIV/AIDS

    • Diabetes mellitus

    • untreated hypothyroidism

    • gastroesophageal reflux disease

    • Sjögren's disease

    • Salivary gland disease

    • Vitamin B-, folic acid- and iron deficiency

    • Medications causing hyposalivation

    • Inflammatory, viral, bacterial, fungal, autoimmune and other diseases of the oral mucosa

    • Insufficient prosthodontics

    • Allergy against acrylic resin of prosthesis

    • Allergy against Chinin-hydrochloride

    • Xerostomia

    • Pregnancy

    • Psychiatric disorder

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Charité - Universitätsmedizin Berlin, Center for dental and craniofacial sciences, Department of restorative dentistry Berlin Germany D-14197

    Sponsors and Collaborators

    • Markus R. Fussnegger
    • Deutsche Gesellschaft für Zahn-, Mund- und Kieferheilkunde e.V.

    Investigators

    • Study Chair: Ingrid Peroz, PD Dr., Charité - Universitätsmedizin Berlin, Center for dental and craniofacial sciences, Department of restorative dentistry, Assmannshauser Str. 4-6, D-14197 Berlin
    • Study Director: Markus R Fussnegger, Dr., Charité - Universitätsmedizin Berlin, Center for dental and craniofacial sciences, Department of restorative dentistry, Assmannshauser Str. 4-6, D-14197 Berlin

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Markus R. Fussnegger, Assistent professor, Charite University, Berlin, Germany
    ClinicalTrials.gov Identifier:
    NCT00504387
    Other Study ID Numbers:
    • EA4/036/06
    First Posted:
    Jul 20, 2007
    Last Update Posted:
    Dec 21, 2012
    Last Verified:
    Dec 1, 2012

    Study Results

    No Results Posted as of Dec 21, 2012